月度归档： 2026 年 6 月

注：各大公司财政年度的起始时间不同于自然年，因此会出现财政季度、年度等与自然年不一致的情况。

In one of its first launches since being acquired by Danone, Huel is expanding its instant meals range with an entirely new format to deliver its plant-based nutrition solutions.

Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for potential human benefit, engineering a human hookworm parasite, Ancylostoma ceylanicum, to produce and deliver a drug within a living host.

Multiple farmers and ag spray drone specialists have urged the FCC to reverse its bombshell Dec 22, 2025 ruling to block…

Drug collaborations don’t always work out as planned. Sometimes they work out better.When Incyte agreed last year to partner with artificial intelligence (AI) platform developer Genesis Molecular AI to research, discover, and develop at least two small molecule treatments, they designed a collaboration that would generate at least up to $620 million for Genesis, whose foundation models for molecular AI are designed to power agentic drug design and development.

IDMO Cellares and TScan Therapeutics will work together to evaluate automated clinical manufacturing of TSC-101, which is TScan’s lead TCR-T therapy candidate for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Traditionally, antibiotic discovery has involved the isolation of natural products from fungi and bacteria—largely actinomycetes. However, the perception that antibiotic-producing actinomycetes have yielded all they can, with little left to give, has motivated a recent shift toward novel antibiotic discovery processes.

In a new study published in  Nature Communications  titled, “ Native long-read RNA sequencing of human monocytes reveals activation-induced alternative splicing toward functional isoforms , ” researchers at University Medical Center (UMC) Utrecht have uncovered a previously underappreciated mechanism that helps immune cells respond rapidly to infections. The team showed that alternative RNA splicing plays a central role in shaping immune responses. The results provide new insights into immune-mediated diseases, such as infections, rheumatoid arthritis and lupus, and open the door to more targeted therapies.  

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through a collaboration that could generate more than $1.9 billion for the Boston biotech.